Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 14.
Article
Al-Mahdawi, S;
Pinto, RM;
Varshney, D;
Lawrence, L;
Lowrie, MB;
Hughes, S;
Webster, Z;
... Pook, MA; + view all
(2006)
GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
GENOMICS
, 88
(5)
580 - 590.
10.1016/j.ygeno.2006.06.015.
|
|
Alvarez-Erviti, L;
Seow, Y;
Schapira, AH;
Gardiner, C;
Sargent, IL;
Wood, MJA;
Cooper, JM;
(2011)
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.
Neurobiology of Disease
, 42
(3)
360 - 367.
10.1016/j.nbd.2011.01.029.
|
|
Chau, KY;
Cooper, JM;
Schapira, AH;
(2013)
Pramipexole reduces phosphorylation of α-Synuclein at Serine-129.
Journal of Molecular Neuroscience
, 51
pp. 573-580.
10.1007/s12031-013-0030-8.
|
 |
|
Cooper, JM;
Wiklander, PB;
Nordin, JZ;
Al-Shawi, R;
Wood, MJ;
Vithlani, M;
Schapira, AH;
... Alvarez-Erviti, L; + view all
(2014)
Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice.
Mov Disord
, 29
(12)
1476 - 1485.
10.1002/mds.25978.
|
|
|
Gegg, ME;
Cooper, JM;
Schapira, AHV;
Taanman, JW;
(2009)
Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells.
PLOS ONE
, 4
(3)
, Article e4756. 10.1371/journal.pone.0004756.
|
|
|
Izco, M;
Blesa, J;
Verona, G;
Cooper, JM;
Alvarez-Erviti, L;
(2021)
Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson's disease.
Neuroscience Research
, 170
pp. 330-340.
10.1016/j.neures.2020.11.004.
|
|
Izco, M;
Vettorazzi, A;
Forcen, R;
Blesa, J;
De Toro, M;
Alvarez-Herrera, N;
Cooper, JM;
... Alvarez-Erviti, L; + view all
(2021)
Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment.
Food and Chemical Toxicology
, 152
, Article 112164. 10.1016/j.fct.2021.112164.
|
|
Izco, M;
Blesa, J;
Schleef, M;
Schmeer, M;
Porcari, R;
Al-Shawi, R;
Ellmerich, S;
... Alvarez-Erviti, L; + view all
(2019)
Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology.
Molecular Therapy
, 27
(12)
pp. 2111-2122.
10.1016/j.ymthe.2019.08.010.
|
|
Lashley, T;
Tossounian, M-A;
Costello Heaven, N;
Wallworth, S;
Peak-Chew, S;
Bradshaw, A;
Cooper, JM;
... Gout, I; + view all
(2021)
Extensive Anti-CoA Immunostaining in Alzheimer’s Disease and Covalent Modification of Tau by a Key Cellular Metabolite Coenzyme A.
Frontiers in Cellular Neuroscience
, 15
, Article 739425. 10.3389/fncel.2021.739425.
|
 |
|
McNeill, A;
Magalhaes, J;
Shen, C;
Chau, KY;
Hughes, D;
Mehta, A;
Foltynie, T;
... Schapira, AH; + view all
(2014)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
Brain
, 137
(5)
pp. 1481-1495.
10.1093/brain/awu020.
|
|
|
Pichler, I;
Del Greco, MF;
Gogele, M;
Lill, CM;
Bertram, L;
Do, CB;
Eriksson, N;
... Minelli, C; + view all
(2013)
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.
PLoS.Med.
, 10
(6)
, Article e1001462. 10.1371/journal.pmed.1001462.
|
|
|
Plagnol, V;
Nalls, MA;
Bras, JM;
Hernandez, DG;
Sharma, M;
Sheerin, UM;
Saad, M;
... WTCCC2; + view all
(2011)
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease.
PLoS Genetics
, 7
(6)
, Article e1002142. 10.1371/journal.pgen.1002142.
|
|
|
Robak, LA;
Jansen, IE;
van Rooij, J;
Uitterlinden, AG;
Kraaij, R;
Jankovic, J;
Heutink, P;
(2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
Brain
, 140
(12)
pp. 3191-3203.
10.1093/brain/awx285.
|
|
Yakhine-Diop, SMS;
Niso-Santano, M;
Rodríguez-Arribas, M;
Gómez-Sánchez, R;
Martínez-Chacón, G;
Uribe-Carretero, E;
Navarro-García, JA;
... Fuentes, JM; + view all
(2019)
Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.
Molecular Neurobiology
, 56
(4)
pp. 2466-2481.
10.1007/s12035-018-1206-6.
|
